Tirzepatide – 20mg

Tirzepatide is a dual incretin peptide that activates both GLP-1 (glucagon-like peptide-1)
and GIP (glucose-dependent insulinotropic polypeptide) receptors.
This dual-agonist activity has generated strong interest in research settings for
weight management, glycemic control, and lipid metabolism.
The 20mg vial provides a balanced dosage format for metabolic investigations.

Potential Research Benefits

• Studied for obesity and weight management research
• Explored for improving insulin sensitivity
• Supports glucose regulation studies
• Dual receptor action on GLP-1 & GIP pathways

Scientific Background

Tirzepatide’s dual action engages both incretin pathways, leading to potential
synergistic effects in metabolism and energy balance.
Research findings suggest improvements in weight reduction, appetite regulation,
and glycemic control.
Its unique incretin profile sets it apart from single-agonist peptides
in the study of metabolic disorders and obesity.

Product Details

• Compound: Tirzepatide
• Form: Lyophilized Powder
• Amount: 20mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption